BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piorecka K, Smith D, Kurjata J, Stanczyk M, Stanczyk WA. Synthetic routes to nanoconjugates of anthracyclines. Bioorg Chem 2020;96:103617. [PMID: 32014639 DOI: 10.1016/j.bioorg.2020.103617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng B, Tang X, Wang Y. Role of microRNA-129 in cancer and non-cancerous diseases (Review). Exp Ther Med 2021;22:918. [PMID: 34335879 DOI: 10.3892/etm.2021.10350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Du BW, Chu CY, Lin CC, Ko FH. The Multifunctionally Graded System for a Controlled Size Effect on Iron Oxide-Gold Based Core-Shell Nanoparticles. Nanomaterials (Basel) 2021;11:1695. [PMID: 34203315 DOI: 10.3390/nano11071695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Piorecka K, Kurjata J, Stanczyk WA. Novel Polyhedral Silsesquioxanes [POSS(OH)32] as Anthracycline Nanocarriers-Potential Anticancer Prodrugs. Molecules 2020;26:E47. [PMID: 33374161 DOI: 10.3390/molecules26010047] [Reference Citation Analysis]
4 Piorecka K, Janaszewska A, Majkowska M, Marcinkowska M, Kurjata J, Kazmierski S, Radzikowska-Cieciura E, Kost B, Sowinski P, Klajnert-Maculewicz B, Stanczyk WA. Hydrophilic Polyhedral Oligomeric Silsesquioxane, POSS(OH)32, as a Complexing Nanocarrier for Doxorubicin and Daunorubicin. Materials (Basel) 2020;13:E5512. [PMID: 33287168 DOI: 10.3390/ma13235512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Lu B, Xiao F, Wang Z, Wang B, Pan Z, Zhao W, Zhu Z, Zhang J. Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy. ACS Biomater Sci Eng 2020;6:4106-15. [DOI: 10.1021/acsbiomaterials.0c00762] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
6 Piorecka K, Kurjata J, Bak-Sypien I, Cypryk M, Steinke U, Stanczyk WA. Reasons for enhanced activity of doxorubicin on co-delivery with octa(3-aminopropyl)silsesquioxane. RSC Adv 2020;10:15579-85. [PMID: 35495453 DOI: 10.1039/d0ra01319f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]